This article was originally published in The Gray Sheet
FDA and the Central Atlantic States Association of Food and Drug Officials are offering a series of two-day workshops in June and July on the proposed hazard analysis and critical control points inspection process for devices. For more information, contact Joseph Salyer at 301/594-4595, ext. 175
You may also be interested in...
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.